A proper understanding of the disease of the anorectum in the HIV-positive population mandates a familiarity with the ongoing advances in antiviral chemotherapy, mechanisms of oncogenesis, and effect of HIV infection on wound dynamics. As the prognosis for HIV-infected patients improves, therapies must reflect the expected increased survival of these patients.